Helbig B - Search Results

1

Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations-relevance for the incidence of genital herpes.

Wutzler P, Doerr HW, Färber I, Eichhorn U, Helbig B, Sauerbrei A, Brandstädt A, Rabenau HF. Wutzler P, et al. Among authors: helbig b. J Med Virol. 2000 Jun;61(2):201-7. doi: 10.1002/(sici)1096-9071(200006)61:2<201::aid-jmv5>3.0.co;2-p. J Med Virol. 2000. PMID: 10797375

2

Therapeutic effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine, caffeic acid oxidation product, and trisodiumphosphonoformate on cutaneous herpes simplex virus type 1 infection in guinea pigs.

Helbig B, Sauerbrei A, Klöcking R, Wutzler P, Wicht N, Wiedemann U, Herrmann G. Helbig B, et al. J Med Virol. 1987 Nov;23(3):303-9. doi: 10.1002/jmv.1890230314. J Med Virol. 1987. PMID: 2828526

3

In vitro activity of polyhydroxycarboxylates against herpesviruses and HIV.

Meerbach A, Neyts J, Balzarini J, Helbig B, De Clercq E, Wutzler P. Meerbach A, et al. Among authors: helbig b. Antivir Chem Chemother. 2001 Nov;12(6):337-45. doi: 10.1177/095632020101200603. Antivir Chem Chemother. 2001. PMID: 12018678 Free article.

4

Inhibitory effect of cycloSaligenyl-nucleoside monophosphates (cycloSal-NMP) of acyclic nucleoside analogues on HSV-1 and EBV.

Meerbach A, Klöcking R, Meier C, Lomp A, Helbig B, Wutzler P. Meerbach A, et al. Among authors: helbig b. Antiviral Res. 2000 Jan;45(1):69-77. doi: 10.1016/s0166-3542(99)00076-5. Antiviral Res. 2000. PMID: 10774591

5

Anti-HSV-1 activity of synthetic humic acid-like polymers derived from p-diphenolic starting compounds.

Klöcking R, Helbig B, Schötz G, Schacke M, Wutzler P. Klöcking R, et al. Among authors: helbig b. Antivir Chem Chemother. 2002 Jul;13(4):241-9. doi: 10.1177/095632020201300405. Antivir Chem Chemother. 2002. PMID: 12495212 Free article.

6

Antiviral activity of enzymatically oxidized caffeic acid against herpesvirus hominis type 1 and type 2.

Thiel KD, Helbig B, Sprössig M, Klöcking R, Wutzler P. Thiel KD, et al. Among authors: helbig b. Acta Virol. 1983 May;27(3):200-8. Acta Virol. 1983. PMID: 6138980

7

Selective inhibitory activity of polyhydroxycarboxylates derived from phenolic compounds against human immunodeficiency virus replication.

Schols D, Wutzler P, Klöcking R, Helbig B, De Clercq E. Schols D, et al. Among authors: helbig b. J Acquir Immune Defic Syndr (1988). 1991;4(7):677-85. J Acquir Immune Defic Syndr (1988). 1991. PMID: 1675677

8

In vitro activity of cycloSal-nucleoside monophosphates and polyhydroxycarboxylates against orthopoxviruses.

Sauerbrei A, Meier C, Meerbach A, Schiel M, Helbig B, Wutzler P. Sauerbrei A, et al. Among authors: helbig b. Antiviral Res. 2005 Sep;67(3):147-54. doi: 10.1016/j.antiviral.2005.06.001. Antiviral Res. 2005. PMID: 16076502

9

[Comparison of the in vitro activities of ammonium humate and of enzymically oxidized chlorogenic and caffeic acids against type 1 and type 2 human herpes virus (author's transl)].

Thiel KD, Helbig B, Klöcking R, Wutzler P, Sprössig M, Schweizer H. Thiel KD, et al. Among authors: helbig b. Pharmazie. 1981;36(1):50-3. Pharmazie. 1981. PMID: 6261267 German.

10

[Penetration kinetics of potential virustatics into the human skin].

Wohlrab W, Helbig B, Klöcking R, Sprössig M. Wohlrab W, et al. Among authors: helbig b. Pharmazie. 1984 Aug;39(8):562-4. Pharmazie. 1984. PMID: 6504982 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results